BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30914310)

  • 41. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
    Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
    BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study.
    Wu LL; Li CW; Lin WK; Qiu LH; Xie D
    BMC Cancer; 2021 Sep; 21(1):1009. PubMed ID: 34496775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008-2012.
    Andreano A; Peake MD; Janes SM; Valsecchi MG; Pritchard-Jones K; Hoag JR; Gross CP
    J Thorac Oncol; 2018 Jul; 13(7):904-914. PubMed ID: 29727739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.
    Shaverdian N; Veruttipong D; Wang J; Kupelian P; Steinberg M; Lee P
    Clin Lung Cancer; 2017 Mar; 18(2):e137-e142. PubMed ID: 27908620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival disparities following surgery among patients with different histological types of non-small cell lung cancer.
    Grosu HB; Manzanera A; Shivakumar S; Sun S; Noguras Gonzalez G; Ost DE
    Lung Cancer; 2020 Feb; 140():55-58. PubMed ID: 31865279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
    Urban D; Bar J; Solomon B; Ball D
    J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer.
    Fink-Neuboeck N; Lindenmann J; Porubsky C; Fediuk M; Anegg U; Maier A; Smolle J; Lamont E; Smolle-Juettner FM
    Clin Lung Cancer; 2020 Jul; 21(4):333-340. PubMed ID: 32273257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer.
    Baine MJ; Verma V; Schonewolf CA; Lin C; Simone CB
    Lung Cancer; 2018 Apr; 118():20-26. PubMed ID: 29571997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.
    Zhang J; Gold KA; Lin HY; Swisher SG; Xing Y; Lee JJ; Kim ES; William WN
    J Thorac Oncol; 2015 Apr; 10(4):682-90. PubMed ID: 25590605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of clinical characteristics on outcomes from maintenance therapy in non-small cell lung cancer: A systematic review with meta-analysis.
    Zhou F; Jiang T; Ma W; Gao G; Chen X; Zhou C
    Lung Cancer; 2015 Aug; 89(2):203-11. PubMed ID: 26115839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancer.
    Kulasinghe A; Kapeleris J; Kimberley R; Mattarollo SR; Thompson EW; Thiery JP; Kenny L; O'Byrne K; Punyadeera C
    Cancer Med; 2018 Dec; 7(12):5910-5919. PubMed ID: 30565869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.
    Boyer MJ; Williams CD; Harpole DH; Onaitis MW; Kelley MJ; Salama JK
    J Thorac Oncol; 2017 Dec; 12(12):1814-1823. PubMed ID: 28951090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
    She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
    JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer.
    Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnicka AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Jun; 99(6):1921-8. PubMed ID: 25912748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
    Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
    J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.
    Speirs CK; DeWees TA; Rehman S; Molotievschi A; Velez MA; Mullen D; Fergus S; Trovo M; Bradley JD; Robinson CG
    J Thorac Oncol; 2017 Feb; 12(2):293-301. PubMed ID: 27743888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.
    Pruitt SL; Laccetti AL; Xuan L; Halm EA; Gerber DE
    Br J Cancer; 2017 Mar; 116(6):717-725. PubMed ID: 28196065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.
    Lin L; Wang D; Chen H
    PLoS One; 2023; 18(5):e0285766. PubMed ID: 37195975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases.
    Wang J; Liu Z; Pang Q; Zhang T; Chen X; Er P; Wang Y; Wang P; Wang J
    BMC Cancer; 2020 Sep; 20(1):837. PubMed ID: 32883221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.